Skip to main content
Year archive

Lineage Cell Therapeutics Inc. — 2022 filings

All 190 regulatory filings released by Lineage Cell Therapeutics Inc. (LCTX) in 2022, sourced directly from the official regulator.

190 Filings
2022 Period
2022 filings (190)
Filing Released Lang
Lineage Announces Launch of Phase 2a Study by Genentech of RG6501 (OpRegen®) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Legal Proceedings Report
2022-11-28 English
Lineage Announces Launch of Phase 2a Study by Genentech of RG6501 (OpRegen®) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Report Publication Announcement
2022-11-28 English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES - Howe Jill Ann
Major Shareholding Notification
2022-11-17 English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES - Howe Jill Ann
Director's Dealing
2022-11-17 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-11-17 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-11-17 English
Director's Dealing 2022
Director's Dealing
2022-11-16 English
Director's Dealing 2022
Director's Dealing
2022-11-16 English
8K- THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Earnings Release Q3 2022
2022-11-13 English
8K- THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Regulatory Filings
2022-11-13 English
10-Q- THIRD QUARTER RESULTS FOR 2022
Interim / Quarterly Report Q3 2022
2022-11-13 English
10-Q- THIRD QUARTER RESULTS FOR 2022
Report Publication Announcement Q3 2022
2022-11-13 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Q3 2022
2022-11-10 English
Regulatory Filings 2022
Regulatory Filings
2022-11-10 English
Lineage Cell Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on November 10, 2022
Earnings Release Q3 2022
2022-11-03 English
Lineage Cell Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on November 10, 2022
Report Publication Announcement
2022-11-03 English
The company Announces the Appointment of Ms. Jill A. Howe as its Chief Financial Officer, effective November 14, 2022
Board/Management Information
2022-10-31 English
The company Announces the Appointment of Ms. Jill A. Howe as its Chief Financial Officer, effective November 14, 2022
Board/Management Information
2022-10-31 English
Regulatory Filings 2022
Regulatory Filings
2022-10-31 English
Agreement of Compromise and Settlement was entered into by the plaintiff, subject to Court approval
Regulatory Filings
2022-10-30 English
Agreement of Compromise and Settlement was entered into by the plaintiff, subject to Court approval
Regulatory Filings
2022-10-30 English
Regulatory Filings 2022
Regulatory Filings
2022-10-28 English
Lineage Announces Notice of Allowance of Two Patents Covering Processes for Manufacturing Allogeneic Oligodendrocyte Progenitor and Retinal Pigmented Epithelium Cells
Regulatory Filings
2022-10-11 English
Lineage Announces Notice of Allowance of Two Patents Covering Processes for Manufacturing Allogeneic Oligodendrocyte Progenitor and Retinal Pigmented Epithelium Cells
Report Publication Announcement
2022-10-11 English
Lineage to Present at Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa
Regulatory Filings
2022-10-06 English
Lineage to Present at Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa
Report Publication Announcement
2022-10-06 English
ineage Establishes New R&D Facility in U.S. and Expands Current GMP Manufacturing Facility in Israel
Regulatory Filings
2022-10-06 English
ineage Establishes New R&D Facility in U.S. and Expands Current GMP Manufacturing Facility in Israel
Report Publication Announcement
2022-10-06 English
FORM 8-K - Amended and Restated Employment Agreements -Amended report
Remuneration Information
2022-10-02 English
FORM 8-K - Amended and Restated Employment Agreements -Amended report
Regulatory Filings
2022-10-02 English
Regulatory Filings 2022
Regulatory Filings
2022-09-30 English
FORM 8-K - Amended and Restated Employment Agreements
Regulatory Filings
2022-09-28 English
FORM 8-K - Amended and Restated Employment Agreements
Regulatory Filings
2022-09-28 English
Regulatory Filings 2022
Regulatory Filings
2022-09-26 English
LINEAGE TO PRESENT AT H.C. WAINWRIGHT & CO. 2ND ANNUAL VIRTUAL OPHTHALMOLOGY CONFERENCE
Regulatory Filings
2022-08-15 English
LINEAGE TO PRESENT AT H.C. WAINWRIGHT & CO. 2ND ANNUAL VIRTUAL OPHTHALMOLOGY CONFERENCE
Report Publication Announcement
2022-08-15 English
FORM 8-K- Financial Results Q2 2022
Earnings Release Q2 2022
2022-08-14 English
FORM 8-K- Financial Results Q2 2022
Report Publication Announcement
2022-08-14 English
FORM 10-Q- First Half 2022 Financial Results
Interim / Quarterly Report H1 2022
2022-08-14 English
FORM 10-Q- First Half 2022 Financial Results
Report Publication Announcement Q2 2022
2022-08-14 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Q2 2022
2022-08-11 English
Regulatory Filings 2022
Regulatory Filings
2022-08-11 English
Report Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
Earnings Release Q2 2022
2022-08-04 English
Report Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
Report Publication Announcement
2022-08-04 English
SCHEDULE 13G-BlackRock, Inc
Major Shareholding Notification
2022-07-10 English
SCHEDULE 13G-BlackRock, Inc
Director's Dealing
2022-07-10 English
Departure of the CFO of the Company
Board/Management Information
2022-07-10 English
Departure of the CFO of the Company
Report Publication Announcement
2022-07-10 English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hernandez Alexandra
Major Shareholding Notification
2022-07-10 English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hernandez Alexandra
Director's Dealing
2022-07-10 English
Director's Dealing 2022
Director's Dealing
2022-07-09 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-07-08 English
Regulatory Filings 2022
Regulatory Filings
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Russel Angus C
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Russel Angus C
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Mulroy Michael H
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Mulroy Michael H
Director's Dealing
2022-07-07 English
Statement of Changes in Beneficial Ownership - Kingsley Alfred D
Director's Dealing
2022-07-07 English
Statement of Changes in Beneficial Ownership - Kingsley Alfred D
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Jayasuriya Anula
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Jayasuriya Anula
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Bradsher Neal C
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Bradsher Neal C
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP- Bailey Don M
Director's Dealing
2022-07-07 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP- Bailey Don M
Director's Dealing
2022-07-07 English
Statement of Changes in Beneficial Ownership - Andrews Deborah J
Director's Dealing
2022-07-07 English
Statement of Changes in Beneficial Ownership - Andrews Deborah J
Director's Dealing
2022-07-07 English
Statement of Changes in Beneficial Ownership - Amin Dipti
Director's Dealing
2022-07-07 English
Statement of Changes in Beneficial Ownership - Amin Dipti
Major Shareholding Notification
2022-07-07 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
Director's Dealing 2022
Director's Dealing
2022-07-06 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Culley Brian M
Director's Dealing
2022-07-03 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Culley Brian M
Director's Dealing
2022-07-03 English
Director's Dealing 2022
Director's Dealing
2022-06-30 English
General Meeting Results
Declaration of Voting Results & Voting Rights Announcements
2022-06-19 English
General Meeting Results
Report Publication Announcement
2022-06-19 English
Regulatory Filings 2022
Regulatory Filings
2022-06-17 English
Lineage Broadens Collaboration With Advanced BioMatrix for HyStem® Cell Drug Delivery Technology
Regulatory Filings
2022-06-02 English
Lineage Broadens Collaboration With Advanced BioMatrix for HyStem® Cell Drug Delivery Technology
Report Publication Announcement
2022-06-02 English
Form 10-Q-REPORTS FIRST QUARTER 2022
Interim / Quarterly Report Q1 2022
2022-05-13 English
Form 10-Q-REPORTS FIRST QUARTER 2022
Report Publication Announcement Q1 2022
2022-05-13 English
8k- REPORTS FIRST QUARTER 2022
Earnings Release Q1 2022
2022-05-13 English
8k- REPORTS FIRST QUARTER 2022
Report Publication Announcement
2022-05-13 English
REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Earnings Release Q1 2022
2022-05-13 English
REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Report Publication Announcement Q1 2022
2022-05-13 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Q1 2022
2022-05-12 English
Regulatory Filings 2022
Regulatory Filings
2022-05-12 English
8K-RG6501 (OPREGEN®) PHASE 1/2A CLINICAL RESULTS
Regulatory Filings
2022-05-12 English
8K-RG6501 (OPREGEN®) PHASE 1/2A CLINICAL RESULTS
Report Publication Announcement
2022-05-12 English
Regulatory Filings 2022
Regulatory Filings
2022-05-12 English
LINEAGE CELL THERAPEUTICS TO REPORT FIRST QUARTER 2022 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MAY 12, 2022
Report Publication Announcement
2022-05-08 English
LINEAGE CELL THERAPEUTICS TO REPORT FIRST QUARTER 2022 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MAY 12, 2022
Report Publication Announcement
2022-05-08 English
RG6501 (OPREGEN®) PHASE 1/2A CLINICAL RESULTS SUPPORT THE POTENTIAL FOR OPREGEN TO SLOW, STOP OR REVERSE DISEASE PROGRESSION IN GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Earnings Release Q2 2022
2022-05-03 English
RG6501 (OPREGEN®) PHASE 1/2A CLINICAL RESULTS SUPPORT THE POTENTIAL FOR OPREGEN TO SLOW, STOP OR REVERSE DISEASE PROGRESSION IN GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Report Publication Announcement
2022-05-03 English
Proxy Statement for the shareholders meeting to be held on June 16,2022
Proxy Solicitation & Information Statement
2022-05-01 English
Proxy Statement for the shareholders meeting to be held on June 16,2022
Proxy Solicitation & Information Statement
2022-05-01 English
ANNUAL MEETING OF SHAREHOLDERS To Be Held June 16, 2022
Proxy Solicitation & Information Statement
2022-05-01 English
ANNUAL MEETING OF SHAREHOLDERS To Be Held June 16, 2022
AGM Information
2022-05-01 English
Regulatory Filings 2022
Regulatory Filings
2022-04-29 English
Proxy Solicitation & Information Statement 2022
Proxy Solicitation & Information Statement
2022-04-29 English
TO PRESENT AT B. RILEY SECURITIES 2022 NEURO & OPHTHALMOLOGY VIRTUAL INVESTOR CONFERENCE ON APRIL 27, 2022
Investor Presentation
2022-04-26 English
TO PRESENT AT B. RILEY SECURITIES 2022 NEURO & OPHTHALMOLOGY VIRTUAL INVESTOR CONFERENCE ON APRIL 27, 2022
Report Publication Announcement
2022-04-26 English
LINEAGE ANNOUNCES A FIFTH CELL THERAPY PROGRAM: ALLOGENEIC PHOTORECEPTOR TRANSPLANTS FOR THE TREATMENT OF DISEASES WHICH MAY LEAD TO BLINDNESS
Regulatory Filings
2022-04-25 English
LINEAGE ANNOUNCES A FIFTH CELL THERAPY PROGRAM: ALLOGENEIC PHOTORECEPTOR TRANSPLANTS FOR THE TREATMENT OF DISEASES WHICH MAY LEAD TO BLINDNESS
Regulatory Filings
2022-04-25 English
LINEAGE AND CANCER RESEARCH UK ANNOUNCE COMPLETION OF PATIENT ENROLLMENT IN PHASE 1 CLINICAL STUDY OF VAC2 FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
Earnings Release Q2 2022
2022-04-13 English
LINEAGE AND CANCER RESEARCH UK ANNOUNCE COMPLETION OF PATIENT ENROLLMENT IN PHASE 1 CLINICAL STUDY OF VAC2 FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
Report Publication Announcement
2022-04-13 English
LINEAGE TO PRESENT AT THE NOBLECON18 INVESTOR CONFERENCE ON APRIL 20, 2022
Investor Presentation
2022-04-11 English
LINEAGE TO PRESENT AT THE NOBLECON18 INVESTOR CONFERENCE ON APRIL 20, 2022
Report Publication Announcement
2022-04-11 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP- Culley Brian M -Form 4
Director's Dealing
2022-04-05 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP- Culley Brian M -Form 4
Director's Dealing
2022-04-05 English
Director's Dealing 2022
Director's Dealing
2022-04-04 English
FORM 4-Statement of Changes in Beneficial Ownership - Amin Dipti
Director's Dealing
2022-03-30 English
FORM 4-Statement of Changes in Beneficial Ownership - Amin Dipti
Director's Dealing
2022-03-30 English
Director's Dealing 2022
Director's Dealing
2022-03-29 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-03-29 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Major Shareholding Notification
2022-03-29 English
Director's Dealing 2022
Director's Dealing
2022-03-29 English
Statement of Changes in Beneficial Ownership - BROADWOOD PARTNERS, L.P.
Director's Dealing
2022-03-27 English
Statement of Changes in Beneficial Ownership - BROADWOOD PARTNERS, L.P.
Director's Dealing
2022-03-27 English
SCHEDULE 13D-Broadwood Partners, L.P.
Major Shareholding Notification
2022-03-27 English
SCHEDULE 13D-Broadwood Partners, L.P.
Regulatory Filings
2022-03-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-03-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-03-27 English
Director's Dealing 2022
Director's Dealing
2022-03-25 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-03-25 English
Director's Dealing 2022
Director's Dealing
2022-03-25 English
LINEAGE TO PRESENT AT THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC ON MARCH 28, 2022
Investor Presentation
2022-03-24 English
LINEAGE TO PRESENT AT THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC ON MARCH 28, 2022
Report Publication Announcement
2022-03-24 English
LINEAGE ANNOUNCES PIPELINE EXPANSION TO INCLUDE AUDITORY NEURONAL CELL THERAPY FOR TREATMENT OF HEARING LOSS
Regulatory Filings
2022-03-21 English
LINEAGE ANNOUNCES PIPELINE EXPANSION TO INCLUDE AUDITORY NEURONAL CELL THERAPY FOR TREATMENT OF HEARING LOSS
Report Publication Announcement
2022-03-21 English
RG6501 (OPREGEN®) FULL PHASE 1/2A RESULTS TO BE FEATURED AT 2022 ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY (ARVO) ANNUAL MEETING IN PRESENTATION BY ALLEN C. HO, M.D., FACS
Regulatory Filings
2022-03-14 English
RG6501 (OPREGEN®) FULL PHASE 1/2A RESULTS TO BE FEATURED AT 2022 ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY (ARVO) ANNUAL MEETING IN PRESENTATION BY ALLEN C. HO, M.D., FACS
Report Publication Announcement
2022-03-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Hogge Gary S
Director's Dealing
2022-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Hogge Gary S
Major Shareholding Notification
2022-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Culley Brian M.
Director's Dealing
2022-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Culley Brian M.
Major Shareholding Notification
2022-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Cook Kevin Leon
Director's Dealing
2022-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Cook Kevin Leon
Major Shareholding Notification
2022-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Samuel George A. III
Director's Dealing
2022-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Samuel George A. III
Director's Dealing
2022-03-13 English
Form 10K- Annual financial report for the year ended December 31, 2021
Annual Report FY 2021
2022-03-13 English
Form 10K- Annual financial report for the year ended December 31, 2021
Report Publication Announcement FY 2021
2022-03-13 English
8K- financial results for the quarter and year ended December 30, 2021
Earnings Release Q4 2021
2022-03-13 English
8K- financial results for the quarter and year ended December 30, 2021
Report Publication Announcement
2022-03-13 English
LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Earnings Release Q4 2021
2022-03-13 English
LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Report Publication Announcement
2022-03-13 English
Director's Dealing 2022
Director's Dealing
2022-03-12 English
Director's Dealing 2022
Director's Dealing
2022-03-12 English
Director's Dealing 2022
Director's Dealing
2022-03-12 English
Director's Dealing 2022
Director's Dealing
2022-03-12 English
Annual Report 2021
Annual Report FY 2021
2022-03-10 English
Regulatory Filings 2022
Regulatory Filings
2022-03-10 English
LINEAGE CELL THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MARCH 10, 2022
Report Publication Announcement
2022-03-01 English
LINEAGE CELL THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON MARCH 10, 2022
Report Publication Announcement
2022-03-01 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-02-16 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-02-16 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-02-16 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-02-16 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-02-16 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-02-16 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2022-02-16 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Report Publication Announcement
2022-02-16 English
Director's Dealing 2022
Director's Dealing
2022-02-16 English
Director's Dealing 2022
Director's Dealing
2022-02-16 English
Director's Dealing 2022
Director's Dealing
2022-02-16 English
Director's Dealing 2022
Director's Dealing
2022-02-16 English
the Compensation Committee of the Board of Directors approved RSU to certain of its employees
Regulatory Filings
2022-02-14 English
the Compensation Committee of the Board of Directors approved RSU to certain of its employees
Report Publication Announcement
2022-02-14 English
Regulatory Filings 2022
Regulatory Filings
2022-02-14 English
FORM 5- ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- KINGSLEY ALFRED D
Major Shareholding Notification
2022-02-13 English
FORM 5- ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- KINGSLEY ALFRED D
Major Shareholding Notification
2022-02-13 English
Director's Dealing 2022
Director's Dealing
2022-02-11 English
SCHEDULE 13G-BlackRock, Inc.
Major Shareholding Notification
2022-02-06 English
SCHEDULE 13G-BlackRock, Inc.
Regulatory Filings
2022-02-06 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-04 English
LINEAGE TO PRESENT AT B. RILEY SECURITIES 2022 VIRTUAL ONCOLOGY CONFERENCE ON JANUARY 27, 2022
Regulatory Filings
2022-01-24 English
LINEAGE TO PRESENT AT B. RILEY SECURITIES 2022 VIRTUAL ONCOLOGY CONFERENCE ON JANUARY 27, 2022
Regulatory Filings
2022-01-24 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT H.C. WAINWRIGHT BIOCONNECT VIRTUAL CONFERENCE
Investor Presentation
2022-01-04 English
LINEAGE CELL THERAPEUTICS TO PRESENT AT H.C. WAINWRIGHT BIOCONNECT VIRTUAL CONFERENCE
Report Publication Announcement
2022-01-04 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2022-01-04 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2022-01-04 English
Director's Dealing 2022
Director's Dealing
2022-01-03 English
FORM 4-STATEMENT OF CHANGES IN BEBEFICIAL OWNERSHIP-HOGGE GARY S
Director's Dealing
2022-01-02 English
FORM 4-STATEMENT OF CHANGES IN BEBEFICIAL OWNERSHIP-HOGGE GARY S
Major Shareholding Notification
2022-01-02 English